西亚试剂：Characterization of a Steroid Receptor Coactivator Small Mo

发布时间：2026-02-27

By integrating growth pathways on which cancer cells rely, steroid receptor coactivators (SRC-1, SRC-2, and SRC-3) represent emerging targets in cancer therapeutics. High-throughput screening for SRC small molecule inhibitors (SMIs) uncovered MCB-613 as a potent SRC small molecule “stimulator” (SMS). We demonstrate that MCB-613 can super-stimulate SRCs’ transcriptional activity. Further investigation revealed that MCB-613 increases SRCs’ interactions with other coactivators and markedly induces ER stress coupled to the generation of reactive oxygen species (ROS). Because cancer cells overexpress SRCs and rely on them for growth, we show that we can exploit MCB-613 to selectively induce excessive stress in cancer cells. This suggests that over-stimulating the SRC oncogenic program can be an effective strategy to kill cancer cells

以上资料由西亚试剂：http://www.xiyashiji.com/ 提供

上一篇：西亚试剂：发现鞘磷脂能够激活丙型肝炎病毒RNA聚合酶
下一篇：西亚试剂：SUMOylation水平与细菌感染